MAPT and Alzheimer disease: Aβ/Tau pathology-dependent loss of LAMP5+ interneurons in AD mouse models and human AD/FTLD-tau may therefore directly contribute to the neuronal network aberrations and symptoms reported in the disease models and affected humans.